Display options
Share it on

Breast Care (Basel). 2013 Dec;8(6):408-13. doi: 10.1159/000357534.

Genomic profiling in triple-negative breast cancer.

Breast care (Basel, Switzerland)

Cornelia Liedtke, Christof Bernemann, Ludwig Kiesel, Achim Rody

Affiliations

  1. Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein/Campus Lübeck, Germany.
  2. Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster, Germany.

PMID: 24550748 PMCID: PMC3919434 DOI: 10.1159/000357534

Abstract

Triple-negative breast cancer (TNBC) is defined by a lack of hormone receptor expression as well as lack of overexpression/amplification of HER2/neu. Patients with TNBC show a significantly worse prognosis compared to patients with other breast cancer subtypes. TNBC, however, is a heterogeneous entity both with regard to clinical/pathological characteristics and molecular biology. This review summarizes the current data on TNBC with a particular focus on mutational and gene expression profiling and the association between TNBC and breast cancer stem cells.

Keywords: Heterogeneity; RNA profiling; Triple negative breast cancer, subtypes; Whole genome sequencing

References

  1. Nat Rev Cancer. 2007 Jun;7(6):415-28 - PubMed
  2. Br J Cancer. 2013 Jul 9;109(1):109-13 - PubMed
  3. J Cancer Res Clin Oncol. 2013 May;139(5):739-46 - PubMed
  4. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 - PubMed
  5. Nat Rev Clin Oncol. 2010 Dec;7(12):683-92 - PubMed
  6. Breast Cancer Res Treat. 2013 Feb;138(1):81-90 - PubMed
  7. J Clin Oncol. 2012 Mar 1;30(7):729-34 - PubMed
  8. Am J Pathol. 2009 Jun;174(6):2023-34 - PubMed
  9. Ann Oncol. 2009 Dec;20(12):1913-27 - PubMed
  10. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5 - PubMed
  11. Cell Stem Cell. 2007 Sep 13;1(3):313-23 - PubMed
  12. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 - PubMed
  13. Cell Stem Cell. 2011 Feb 4;8(2):149-63 - PubMed
  14. J Surg Oncol. 2013 Feb;107(2):188-94 - PubMed
  15. Genes Dev. 1999 Sep 1;13(17):2207-17 - PubMed
  16. Oncogene. 2008 Oct 16;27(47):6120-30 - PubMed
  17. Breast Cancer Res. 2008;10(3):R53 - PubMed
  18. Cell. 2008 May 16;133(4):704-15 - PubMed
  19. Cell. 2009 Aug 21;138(4):645-659 - PubMed
  20. Cancer Res. 2008 Feb 15;68(4):989-97 - PubMed
  21. Mol Cancer. 2010 Aug 21;9:221 - PubMed
  22. Clin Cancer Res. 2007 Apr 15;13(8):2329-34 - PubMed
  23. Nature. 2012 Oct 4;490(7418):61-70 - PubMed
  24. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
  25. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  26. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8 - PubMed
  27. Breast Cancer Res. 2011 Oct 06;13(5):R97 - PubMed
  28. Cell Stem Cell. 2007 Nov;1(5):555-67 - PubMed
  29. Nature. 2008 Jan 17;451(7176):345-9 - PubMed
  30. Breast Cancer Res Treat. 2013 Apr;138(2):591-9 - PubMed
  31. N Engl J Med. 2010 Nov 11;363(20):1938-48 - PubMed
  32. Cancer Res. 2009 Feb 15;69(4):1302-13 - PubMed
  33. Eur J Cancer. 2009 Nov;45(16):2792-8 - PubMed
  34. PLoS One. 2008 Aug 06;3(8):e2888 - PubMed
  35. PLoS One. 2012;7(9):e45865 - PubMed
  36. Cell. 2009 Nov 25;139(5):871-90 - PubMed
  37. Nature. 2012 Apr 04;486(7403):395-9 - PubMed
  38. Cell. 2011 Aug 19;146(4):633-44 - PubMed
  39. Cell. 2004 Jun 25;117(7):927-39 - PubMed
  40. J Clin Pathol. 2011 Nov;64(11):937-46 - PubMed
  41. Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60 - PubMed
  42. JAMA. 2006 Jun 7;295(21):2492-502 - PubMed
  43. J Clin Oncol. 2008 Mar 10;26(8):1275-81 - PubMed
  44. Breast Cancer Res Treat. 2009 Nov;118(1):131-7 - PubMed
  45. J Clin Invest. 2011 Jul;121(7):2750-67 - PubMed
  46. Oncologist. 2013;18(2):123-33 - PubMed

Publication Types